Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications

DCLK1 specifically marks colon/pancreatic cancers in mice, and is expressed by human colon adenocarcinomas (hCRCs). Down-regulation of DCLK1 results in loss of cancer-stem-cells (CSCs), and inhibits spheroidal/xenograft growths from hCRC-cells. The 5′-promoter of DCLK1-gene is reportedly hypermethyl...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Connell, Malaney R., Sarkar, Shubhashish, Luthra, Gurinder K., Okugawa, Yoshinaga, Toiyama, Yuji, Gajjar, Aakash H., Qiu, Suimin, Goel, Ajay, Singh, Pomila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597220/
https://www.ncbi.nlm.nih.gov/pubmed/26447334
http://dx.doi.org/10.1038/srep14983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597220/
https://www.ncbi.nlm.nih.gov/pubmed/26447334
http://dx.doi.org/10.1038/srep14983

Ejemplares similares